Study Sheds Light on Telomere Length Inheritance

Telomeres, protective caps at the ends of chromosomes, preserve genetic information much like aglets protect shoelaces from fraying. These repetitive DNA-protein structures degrade over successive cell divisions, and once critically short, they push cells into senescence—a permanent growth arrest state associated with inflammation and age-related disease. Telomere length plays a complex role in health and survival: shorter starting lengths correlate with higher risk of disease and earlier mortality, while overly long telomeres can aid cancer cells in achieving extended lifespans.

In a recent study, scientists at the University of Pennsylvania investigated how telomere length is inherited. Traditionally, questions centered on whether telomere length is influenced by multiple genes, like height or eye color, or whether telomeres themselves are directly passed from egg and sperm. Their findings, published in Current Biology, suggest that inheritance follows neither expectation neatly. Instead, the data point to a parent-of-origin effect, where the relative contributions of maternal and paternal telomeres shape outcomes in the embryo. 

Using mice with naturally long or short telomeres, the researchers performed reciprocal crosses. When mothers contributed short telomeres and fathers contributed long ones, embryos lengthened theirs during early development. When the pairing was reversed, embryos’ telomeres shortened. Because the offspring were genetically identical in both scenarios, differences traced back to telomere inheritance rather than DNA sequence. As senior author Michael Lampson explained, “We wanted to ask how telomeres are really inherited… What we found doesn’t fit neatly into either box.” 

This adjustment happens before embryos activate their own genome, within a brief window between the first two cell divisions. During this stage, telomeres either elongate or shorten in ways that persist through development. The underlying mechanism resembles alternative lengthening of telomeres (ALT), a process previously known from cancer biology. Unlike telomerase, which builds telomeric DNA, ALT copies segments from one chromosome to another. About 10–15% of cancers rely on this pathway. Embryos appear to trigger ALT-like elongation when paternal telomeres are long and maternal telomeres are short, but not in the reverse scenario.

Looking ahead, the team is turning to long-read genome sequencing of human family trios to assess whether similar effects occur in people. They are also probing how embryonic ALT initiation might inform cancer research, where the pathway is usually studied only after it is well established in tumors.